Annual CFF
$54.32 M
+$16.93 M+45.28%
31 December 2023
Summary:
Dyne Therapeutics annual cash flow from financing activities is currently $54.32 million, with the most recent change of +$16.93 million (+45.28%) on 31 December 2023. During the last 3 years, it has fallen by -$326.37 million (-85.73%). DYN annual CFF is now -85.73% below its all-time high of $380.69 million, reached on 31 December 2020.DYN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$18.01 M
-$361.85 M-95.26%
30 September 2024
Summary:
Dyne Therapeutics quarterly cash flow from financing activities is currently $18.01 million, with the most recent change of -$361.85 million (-95.26%) on 30 September 2024. Over the past year, it has increased by +$17.55 million (+3866.74%). DYN quarterly CFF is now -95.59% below its all-time high of $408.39 million, reached on 31 March 2024.DYN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$806.41 M
+$17.55 M+2.23%
30 September 2024
Summary:
Dyne Therapeutics TTM cash flow from financing activities is currently $806.41 million, with the most recent change of +$17.55 million (+2.23%) on 30 September 2024. Over the past year, it has increased by +$715.03 million (+782.49%). DYN TTM CFF is now at all-time high.DYN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.3% | +3866.7% | +782.5% |
| 3 y3 years | -85.7% | +3840.7% | +450.3% |
| 5 y5 years | +337.3% | - | - |
DYN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.7% | +45.3% | -95.6% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5 years | -85.7% | +337.3% | -95.6% | +260.9% | at high | >+9999.0% |
| alltime | all time | -85.7% | +337.3% | -95.6% | +260.9% | at high | >+9999.0% |
Dyne Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.01 M(-95.3%) | $806.41 M(+2.2%) |
| June 2024 | - | $379.86 M(-7.0%) | $788.85 M(+81.8%) |
| Mar 2024 | - | $408.39 M(>+9900.0%) | $433.89 M(+698.7%) |
| Dec 2023 | $54.32 M(+45.3%) | $147.00 K(-67.6%) | $54.32 M(-40.6%) |
| Sept 2023 | - | $454.00 K(-98.2%) | $91.38 M(+0.4%) |
| June 2023 | - | $24.91 M(-13.6%) | $90.99 M(+37.5%) |
| Mar 2023 | - | $28.82 M(-22.5%) | $66.19 M(+77.0%) |
| Dec 2022 | $37.39 M | $37.20 M(>+9900.0%) | $37.39 M(>+9900.0%) |
| Sept 2022 | - | $70.00 K(-29.3%) | $276.00 K(-58.4%) |
| June 2022 | - | $99.00 K(+450.0%) | $663.00 K(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $18.00 K(-79.8%) | $589.00 K(-99.6%) |
| Dec 2021 | $157.82 M(-58.5%) | $89.00 K(-80.5%) | $157.82 M(+7.7%) |
| Sept 2021 | - | $457.00 K(+1728.0%) | $146.54 M(-72.1%) |
| June 2021 | - | $25.00 K(-100.0%) | $526.06 M(+0.0%) |
| Mar 2021 | - | $157.25 M(-1504.8%) | $526.03 M(+38.2%) |
| Dec 2020 | $380.69 M(+1804.5%) | -$11.19 M(-102.9%) | $380.69 M(-2.9%) |
| Sept 2020 | - | $379.98 M(>+9900.0%) | $391.88 M(+3190.9%) |
| June 2020 | - | $0.00(-100.0%) | $11.91 M(0.0%) |
| Mar 2020 | - | $11.91 M | $11.91 M |
| Dec 2019 | $19.99 M(+60.9%) | - | - |
| Dec 2018 | $12.42 M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFF year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFF year-on-year change?
- What is Dyne Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFF year-on-year change?
What is Dyne Therapeutics annual cash flow from financing activities?
The current annual CFF of DYN is $54.32 M
What is the all time high annual CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from financing activities is $380.69 M
What is Dyne Therapeutics annual CFF year-on-year change?
Over the past year, DYN annual cash flow from financing activities has changed by +$16.93 M (+45.28%)
What is Dyne Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DYN is $18.01 M
What is the all time high quarterly CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from financing activities is $408.39 M
What is Dyne Therapeutics quarterly CFF year-on-year change?
Over the past year, DYN quarterly cash flow from financing activities has changed by +$17.55 M (+3866.74%)
What is Dyne Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DYN is $806.41 M
What is the all time high TTM CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from financing activities is $806.41 M
What is Dyne Therapeutics TTM CFF year-on-year change?
Over the past year, DYN TTM cash flow from financing activities has changed by +$715.03 M (+782.49%)